Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Nextleaf Solutions gets key Canadian patent and Health Canada approval for controlled human trials

Nextleaf Solutions gets key Canadian patent and Health Canada approval for controlled human trials

Nextleaf Solutions (CSE: OILS- OTCQB: OILFF) CEO Paul Pedersen joined Steve Darling from Proactive with news the company has been issued its 70th worldwide patent. This one covers the process for acetylating cannabidiol and subsequent refinement of CBD-O-Acetate using a proprietary extraction and distillation technique.

Pedersen also shared with Proactive, Health Canada has granted the company a research licence to conduct controlled human administration trials for sensory evaluation of cannabis at its processing facility in Metro Vancouver.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK